Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: A Bayesian network meta-analysis

Objectives: Tumours remain a serious threat to human life. Following rapid progress in oncology research, tyrosine kinase inhibitors have been used to treat multiple tumour types. Given the great influence of kidneys on pharmacokinetics, renal toxicities associated with TKIs have attracted attention...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Ying, Wang, Qinxuan, Liu, Yangyi, Wei, Jingwen, Chen, Xiaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669664/
https://www.ncbi.nlm.nih.gov/pubmed/36408227
http://dx.doi.org/10.3389/fphar.2022.1023660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669664/
https://www.ncbi.nlm.nih.gov/pubmed/36408227
http://dx.doi.org/10.3389/fphar.2022.1023660

Ejemplares similares